Fauci not disappointed by FDA advisory panel's COVID-19 booster recommendation
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Dr. Anthony Fauci, the nation's top infectious disease expert, said Sunday he's "not necessarily at all" disappointed by the Food and Drug Administration's advisory panel's decision to not recommend COVID-19 vaccine boosters for all Americans.
The advisory panel, which was only looking at data for the Pfizer-BioNTech vaccine, overwhelmingly opted against an additional shot for everyone, and instead approved a third dose for people over 65 or individuals who are at high risk of developing severe COVID-19 infections, either because of underlying health conditions or the nature of their jobs.
Fauci, who backed the White House's push to roll out boosters, noted that "we had said right from the beginning that this would be contingent upon the examination of all of the data that the FDA accumulated that would be discussed with their advisory committee, and that's exactly what happened." At the end of the day, he told ABC News' Martha Raddatz, "I think the process worked."
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
